Bafna Pharmaceuticals net profit declines 42.51% in the September 2013 quarter

Sales decline 16.64% to Rs 46.99 crore

Net profit of Bafna Pharmaceuticals declined 42.51% to Rs 1.19 crore in the quarter ended September 2013 as against Rs 2.07 crore during the previous quarter ended September 2012. Sales declined 16.64% to Rs 46.99 crore in the quarter ended September 2013 as against Rs 56.37 crore during the previous quarter ended September 2012. ParticularsQuarter Ended Sep. 2013Sep. 2012% Var.Sales46.9956.37 -17 OPM %14.0910.79 -PBDT3.184.14 -23 PBT1.752.54 -31 NP1.192.07 -43

Powered by Capital Market - Live News